Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3

Genes and Immunity

Volumn 14, Issue 5, 2013, Pages 310-316

  Zhang, W ^a   Hui, K Y ^a   Gusev, A ^b   Warner, N ^c   Ng, S M E ^a   Ferguson, J ^a   Choi, M ^a   Burberry, A ^c   Abraham, C ^a   Mayer, L ^d   Desnick, R J ^d   Cardinale, C J ^e   Hakonarson, H ^e   Waterman, M ^f   Chowers, Y ^f   Karban, A ^f   Brant, S R ^g   Silverberg, M S ^h   Gregersen, P K ⁱ   Katz, S ^j   Lifton, R P ^a   Zhao, H ^a   Nunez G ^c   Pe'er, I ^k   Peter, I ^d   Cho, J H ^a   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^j NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^k Yale School of Medicine ^*  (United States)

more..

Author keywords

Ashkenazi Jewish; Crohn's disease; Haplotype association; NF B signaling; Synthetic association

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CHROMOSOME 16; CHROMOSOME 2; CHROMOSOME 21; CONTROLLED STUDY; CROHN DISEASE; EXOME; FOLLOW UP; FRAMESHIFT MUTATION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEATR3 GENE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84880923909     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.19     Document Type: Article

References (36)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078.
2. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
3. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-2404. (Pubitemid 40039371)
4. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
5. Mayberry JF, Judd D, Smart H, Rhodes J, Calcraft B, Morris JS. Crohn's disease in Jewish people-an epidemiological study in south-east Wales. Digestion 1986; 35: 237-240. (Pubitemid 17196487)
6. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002. (Pubitemid 43725312)
7. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet 2001; 2: 891-898. (Pubitemid 33674035)
8. Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, Palamara PF et al. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet 2010; 86: 850-859.
9. Bray SM, Mulle JG, Dodd AF, Pulver AE, Wooding S, Warren ST. Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Aca Sci USA 2010; 107: 16222-16227.
10. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variants create synthetic genome-wide associations. PLoS Biol 2010; 8: e1000294.
11. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606. (Pubitemid 32531409)
12. Kang J, Kugathasan S, Georges M, Zhao H, Cho JH. Improved risk prediction for Crohn's disease with a multi-locus approach. Hum Mol Genet 2011; 20: 2435-2442.
13. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463. (Pubitemid 44871953)
14. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A et al. Genomewide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604. (Pubitemid 46676115)
15. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125.
16. Karban A, Atia O, Leitersdorf E, Shahbari A, Sbeit W, Ackerman Z et al. The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohort. Dig Dis Sci 2005; 50: 1692-1697. (Pubitemid 41203664)
17. Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D et al. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet 2011; 12: 63.
18. Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH et al. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol 2004; 99: 306-315. (Pubitemid 38279874)
19. Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Gen 2003; 72: 509-518. (Pubitemid 36255950)
20. Tukel T, Shalata A, Present D, Rachmilewitz D, Mayer L, Grant D et al. Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 2004; 74: 623-636. (Pubitemid 38420093)
21. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T et al. Crohn's diseaseassociated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterol 2003; 124: 140-146. (Pubitemid 36055347)
22. Zhou Z, Lin XY, Akolkar PN, Gulwani-Akolkar B, Levine J, Katz S et al. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002; 97: 3095-3101. (Pubitemid 35424581)
23. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-5512. (Pubitemid 36800790)
24. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872. (Pubitemid 36800360)
25. Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM et al. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet 2012; 8: e1002559.
26. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H et al. BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol 2010; 12: 380-389.
27. Elding H, Lau W, Swallow DM, Maniatis N. Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. Am J Hum Genet 2011; 89: 798-805.
28. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
29. Brant SR, Wang MH, Rawsthorne P, Sargent M, Datta LW, Nouvet F et al. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis. Am J Gastroenterol 2007; 102: 313-323. (Pubitemid 46160545)
30. Maouche S, Poirier O, Godefroy T, Olaso R, Gut I, Collet JP et al. Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells. BMC Genomics 2008; 9: 302.
31. Anderson CA, Soranzo N, Zeggini E, Barrett JC. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011; 9: e1000580.
32. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missingdata inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007; 81: 1084-1097. (Pubitemid 47580259)
33. Gusev A, Kenny EE, Lowe JK, Salit J, Saxena R, Kathiresan S et al. DASH: a method for identical-by-descent haplotype mapping uncovers association with recent variation. Am J Hum Genet 2011; 88: 706-717.
34. Gusev A, Lowe JK, Stoffel M, Daly MJ, Altshuler D, Breslow JL et al. Whole population, genome-wide mapping of hidden relatedness. Genome Res 2009; 19: 318-326.
35. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
36. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303.